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The Ryan Haight Act has established excessive restrictions on controlled
substance prescribing through telemedicine by first requiring an in-person
exam. If the Act is not amended, many individuals in need of medication will
go without proper medical care. While other agencies and states have made
moves to expand telehealth, the DEA has dragged its feet on making any sig-
nificant changes. This Comment argues that the federal government should
amend the Ryan Haight Act, allowing telemedicine providers to prescribe con-
trolled substances without an in-person exam. This amendment would focus
on the standard of care while requiring stringent documentation by physicians
who perform telemedicine services. If this change occurs, patients who have
barriers to accessing medical treatment will have the opportunity to get the
proper care they need.
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I. INTRODUCTION
The federal Ryan Haight Online Pharmacy Consumer Protection
Act places excessive limitations on telemedicine providers. The Act
requires an in-person examination before prescribing a controlled
substance.1 But an evaluation through audiovisual communication
technology can be performed that accomplishes the same result at a
reduced cost to both parties. Individuals who have difficulty meeting
with a physician in person because of barriers to access health care,
whether geographic or due to a lack of transportation, can benefit
from a change in the law that allows physicians to prescribe controlled
substances through telemedicine without forcing the patient to visit a
brick and mortar doctor’s office first. This Comment argues that there
is a way to reform telemedicine prescribing laws that would not be
overly permissive, but would allow telemedicine providers to use ad-
vancements in technology for the benefit of the healthcare industry as
a whole. This Comment also brings to light the unintended conse-
quences the Ryan Haight Act has placed upon individuals with sub-
stance abuse disorders who are in need of medication-assisted
treatment.
Telemedicine is a descriptive term that is commonly used inter-
changeably with “telehealth,” and both terms will be used inter-
changeably throughout this Comment.2 Telemedicine services are
delivered through various devices such as telephone consultations, re-
mote cardiac monitoring, or doctor appointments held through a
video conference.3 The flexibility that telemedicine allows would give
unprecedented access to healthcare services in areas that need signifi-
cant development to eliminate barriers to treatment.4
1. 21 U.S.C. § 829(e)(2)(A)(i) (2012).
2. Kayla R. Bryant, Health Law Daily Wrap Up, STRATEGIC PERSPEC-
TIVES: States Fail to Fully Use Telemedicine to Fight Public Health Crises, WOLTERS
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II. THE FOUNDATION FOR THE RYAN HAIGHT ACT
Clayton Fuchs developed a business plan in the late 1990s which
allowed for the use of his pharmacy license to start an online phar-
macy.5 The issue with his business plan was that the online pharmacy,
Friendly Pharmacy, allowed customers to simply visit its website, eas-
ily complete an online profile, and order any prescription drug of their
choice.6 Then, Fuchs’s online pharmacy would forward the order to a
physician who lived in Texas to fill the prescription without ever
speaking to or physically examining any of the patients.7 The online
pharmacy filled nearly every order placed.8
There is no doubt that taking advantage of the system this way is
not ethical or legal and should be eliminated. Fuchs’s online phar-
macy, and other online pharmacies like his, was the reason for the
Ryan Haight Online Pharmacy Consumer Protection Act’s name.
Ryan Haight was a seventeen-year-old boy who, while in his home,
began buying prescription drugs from Fuchs’s online pharmacy.9 Ryan
purchased Vicodin and other drugs from the online pharmacy, and in
2001, he died of an overdose from these drugs.10 All of Ryan’s drugs
were prescribed without any communication with a physician whatso-
ever.11 Ryan’s story eventually led to the amendment of the Con-
trolled Substances Act in 2009, named the Ryan Haight Online
Pharmacy Consumer Protection Act.12
A. What the Ryan Haight Online Pharmacy Consumer Protection
Act Requires
The Ryan Haight Act was passed to regulate rogue pharmacies—
pharmacies like the one in the story above—from overprescribing
controlled substances online.13 However, although the Act does suc-
cessfully regulate these dangerous rogue pharmacies, it also negatively
affects legitimate healthcare providers that use telemedicine to pre-
scribe controlled substances for the true benefit of their patients.14
5. Bethany Lipman, Prescribing Medicine for Online Pharmacies: An Assessment





9. Id. at 546.
10. Id.
11. See id. at 545–46.
12. Id.
13. Nathaniel M. Lacktman, Telemedicine Prescribing and Controlled Substance
Laws, FOLEY & LARDNER (Apr. 3, 2017), https://www.foley.com/en/insights/publica-
tions/2017/04/telemedicine-prescribing-and-controlled-substances [https://perma.cc/
CN35-UDMQ].
14. Nathaniel M. Lacktman, Prescribing Controlled Substances Without an In-Per-
son Exam: The Practice of Telemedicine Under the Ryan Haight Act, BECKER’S
HEALTHCARE (Apr. 19, 2017), https://www.beckershospitalreview.com/healthcare-in-
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The Ryan Haight Act prohibits prescribing a controlled substance
“as determined under the Federal Food, Drug, and Cosmetic Act . . .
delivered, distributed, or dispensed by means of the Internet without a
valid prescription.”15 A valid prescription is one that is issued for a
legitimate medical purpose in the course of professional practice by
(1) a practitioner that has conducted at least one in-person medical
evaluation of the patient, or (2) a covering practitioner.16 Therefore,
to comply with federal law, a practitioner prescribing a controlled sub-
stance through telemedicine must have already evaluated the patient
in person or have a covering practitioner evaluate the patient. A cov-
ering practitioner is a practitioner who conducts a medical evaluation
at the request of a practitioner who (1) has conducted at least one in-
person evaluation of the patient or an evaluation of the patient
through the practice of telemedicine within the previous twenty-four
months, and (2) is currently unavailable to conduct the evaluation.17
B. Problems with the Ryan Haight Act
While the Ryan Haight Act has helped to reduce the number of up-
and-running rogue online pharmacies in the United States, the Act
has also produced negative results for legitimate telehealth providers.
For example, the exceptions that were carved out in the Ryan Haight
Act for legitimate telehealth providers have not been acted upon by
the Drug Enforcement Agency (“DEA”). One exception states that
the attorney general can issue a special registration to a practitioner to
engage in the practice of telemedicine.18 To receive the special regis-
tration, a practitioner must (1) have a legitimate need for the special
registration, and (2) be registered in the state in which the patient is
located when receiving treatment through telemedicine.19
No practitioner has been given the special registration to date;20 in
fact, the DEA has not even opened the special registration process.21
In 2015, the American Telemedicine Association (“ATA”) sent a let-
ter to the DEA requesting that the DEA open the special registration
process, to allow psychiatrists and physicians to prescribe controlled




15. 21 U.S.C. § 829(e)(1) (2012).
16. Id. § 829(e)(2)(A)(i)–(ii).
17. Id. § 829(e)(2)(C)(i)–(ii).
18. 21 U.S.C. § 831(h) (2012).
19. Id. § 831(h)(1)(A)–(B).
20. Mohana Ravindranath, Doubts Surround Pending DEA Telemedicine Rule,
AM. TELEMEDICINE ASS’N, https://www.americantelemed.org/industry-news/doubts-
surround-pending-dea-telemedicine-rule/ (last visited Sept. 21, 2019) [https://
perma.cc/U9P4-TVSX].
21. Id.
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person exam.22 The letter stated that “the [current] interpretation of
the [Ryan Haight] Act’s general prohibition of prescribing controlled
substances by means of the internet has become overly restrictive.”23
In 2016, the DEA responded that it planned to issue a rule to activate
the special registration process that would allow physicians to pre-
scribe controlled substances through telemedicine without an in-per-
son exam, but this rule has not been released.24 As a result of the
DEA’s reluctance to open the special registration, recent legislation
was passed by the federal government to force the opening of the spe-
cial registration process.25
Therefore, as a result of the Ryan Haight Act being passed, almost
all telemedicine providers that prescribed controlled substances over
the internet without first performing an in-person exam have become
obsolete or are being run illegally. Due to restrictions of the Act, the
federal government is failing to use telemedicine services to their full
potential—like getting medical help to underserved and in-need indi-
viduals across the United States.
C. Telemedicine Classification of Online Pharmacies
Not every online pharmacy is alike; online pharmacies are typically
split up into three classifications.26 Knowing the different classifica-
tions of online pharmacies helps to detect what problems certain phar-
macies may present.27 First, there are “traditional online pharmacies,”
which function similarly to “traditional brick and mortar pharmacies”
and are “often an online extension” of brick and mortar pharmacies.28
These traditional online pharmacies require a prescription from a phy-
sician before an order will be processed for a customer and are simply
an additional way in which patients can fill their existing prescrip-
tion.29 These pharmacies are not the type that the Ryan Haight Act
seeks to regulate.30
22. Lacktman, supra note 13.
23. Id.
24. Id.
25. Jacqueline N. Acosta & Nathaniel M. Lacktman, President Signs New Law
Allowing Telemedicine Prescribing of Controlled Substances: DEA Special Registra-




26. Bob Schultz, Online Pharmacy Regulation: How the Ryan Haight Online Phar-
macy Consumer Protection Act Can Help Solve an International Problem, 16 SAN DI-




30. Id. at 385–86.
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The second classification of online pharmacies is “prescribing-based
site pharmacies.”31 These pharmacies provide prescriptions and medi-
cation to those who visit the website.32 To receive a prescription from
this type of online pharmacy, a customer will typically have a consulta-
tion that consists of not much more than a questionnaire.33 After-
wards, a doctor will review the results of the “consultation” and will
write the prescription.34 There is no physical examination in this type
of online pharmacy.
The third classification of online pharmacies is “rogue online phar-
macies.”35 These pharmacies are the most dangerous to consumers be-
cause they sell prescription medication without receiving a valid
prescription, performing an “online consultation,” or conducting any
type of examination to determine if there is a need for the medica-
tion.36 All a consumer is required to do to receive medication from a
rogue online pharmacy is fill out an order form in which the consumer
selects the desired medication and quantity of that medication, then
merely pay for the medication.37 Rogue online pharmacies generally
operate illegally because licensed practitioners must distribute
pharmaceuticals in accordance with a valid prescription, and this type
of medication-dispensing does not legally meet the standard of a valid
prescription.38
D. State Law Interaction with Federal Law
Many states have passed legislation in recent years that deals di-
rectly with telemedicine and how a patient–practitioner relationship
may be formed. A number of states have developed laws making
telemedicine less restrictive, which would allow a patient–practitioner
relationship to be formed without a prior in-person examination. But
some states have passed laws with similar demands to the Ryan
Haight Act, requiring an in-person exam of some type.39
For example, Texas passed legislation in 2017 making its
telemedicine laws less restrictive, which aligns with many of the legis-
lators’ views that those in rural areas need to have a better opportu-
nity to receive health care and that telemedicine is one way to
accomplish this goal.40 The new Texas law no longer requires an in-
person meeting between practitioner and patient before performing








39. Kimberly Lovett Rockwell, The Promise of Telemedicine, 96 MICH. B. J. 38, 40
(2017).
40. TEX. OCC. CODE § 111.005.
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treatment through telemedicine.41 The Texas Occupations Code de-
scribes ways to establish the practitioner–patient relationship. One
way to establish this relationship is through practitioner compliance
with the proper standard of care and providing “telemedicine medical
services through the use of . . . synchronous audiovisual interaction
between the practitioner and the patient.”42 An example of a synchro-
nous audiovisual interaction is one that is conducted through real-time
video conversations, much like Skype, WebEx, or FaceTime.43
In contrast, the Georgia Administrative Code has placed very re-
strictive regulations on Georgia’s telemedicine providers.44 Georgia’s
regulation states that the Medical Board can take disciplinary action
against a practitioner who is “providing treatment via electronic or
other means unless a history and physical examination of the patient
has been performed by a Georgia licensee.”45 Georgia does not allow
“[p]rescribing controlled substances and/or dangerous drugs for a pa-
tient based solely on a consultation via electronic means with the pa-
tient . . . .”46
Additionally, Alaska has an interesting set of laws regarding
telemedicine that takes federal law into consideration.47 The Alaska
statute states that a physician may not be disciplined for prescribing a
prescription:
drug that is not a controlled substance to a person without con-
ducting a physical examination if (1) the physician or another li-
censed health care provider or physician in the physician’s group
practice is available to provide follow-up care; and (2) the physician
requests that the person consent to sending a copy of all records of
the encounter to the person’s primary care provider . . . and, if the
patient consents, the physician send the records to the person’s pri-
mary care provider.48
Thus, Alaska has complied with the Ryan Haight Act in that it does
not allow controlled substance prescribing at all without a prior in-
person exam, but the Alaska statute opens up the opportunity for
practitioners to prescribe other drugs without first providing an in-
person exam.49 In fact, all Alaska requires is that a physician is “avail-
able” for follow-up care.50
41. Id.
42. Id.
43. Asynchronous vs. Synchronous Video Communications: What’s The Differ-
ence?, PANOPTO (June 2, 2019), https://www.panopto.com/blog/asynchronous-vs-syn-
chronous-video-communications-whats-the-difference/ [https://perma.cc/9PLC-
FNEL].
44. GA. COMP. R. & REGS. R. 360-3-.02.
45. Id.
46. Id.
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This is a small sample of just three states in the United States that
have very different laws. The variance between state laws shows that
the practice of telemedicine is very difficult because one state may
allow telemedicine prescribing without an in-person exam, while a dif-
ferent state requires a prior in-person examination by an in-state li-
censee. Moreover, there are states like Alaska, which has essentially
created a quasi-requirement that a practitioner must be available for a
follow-up. Even though there is patchwork legislation among the
states and physicians would have to be conscientious of the law in the
state or states they are practicing in, the federal government should
give states the freedom to make their own choice of law when it comes
to telemedicine prescribing.
The Supremacy Clause of the United States Constitution states that
federal law trumps state laws that are in conflict with said federal
law.51 Therefore, a practitioner must currently look to both the state
telemedicine laws as well as the federal. But, if choice of telemedicine
law was given to each state, larger states could choose to allow
telemedicine prescribing without an in-person exam so that individu-
als who have barriers to accessing a qualified physician can get proper
medication, while smaller states would have the choice to keep their
telemedicine laws more restrictive.
III. NEWLY ENACTED FEDERAL LEGISLATION
A. What the Legislation Says
For those with substance abuse issues and mental health disorders,
the Ryan Haight Act has had the effect of cutting off medication-as-
sisted treatment, which often utilizes medication labeled a controlled
substance and is thus subject to the Ryan Haight Act.52 Congress did
not realize the Ryan Haight Act would have these unintended conse-
quences when it passed the Act over ten years ago. The negative re-
sult that the Ryan Haight Act has placed upon legitimate telemedicine
providers and individuals in need of medication has been noticed. Re-
cently passed legislation could alleviate some of the problem by al-
lowing certain telemedicine providers to prescribe controlled
substances without the requirement of an in-person examination.53
This legislation would open up the DEA’s special registration process
mentioned previously.
The “SUPPORT for Patients and Communities Act,” which was
signed into law by President Donald Trump in October 2018, contains
a chapter labeled “Special Registration for Telemedicine Clarification
51. U.S. CONST. art. VI, § 2.
52. Bryant, supra note 2, at 2.
53. Acosta & Lacktman, supra note 25.
2020] AMENDING THE RYAN HAIGHT ACT 483
Act of 2018.”54 This chapter establishes regulations that relate to the
special registration exception of the Ryan Haight Act. It states that:
Not later than [one] year after the date of enactment of the SUP-
PORT for Patients and Communities Act, in consultation with the
Secretary, the Attorney General shall promulgate final regulations
specifying . . . the limited circumstances in which a special registra-
tion under this subsection may be issued; and . . . the procedure for
obtaining a special registration under this subsection.55
The proposed legislation originally required that the DEA promul-
gate final regulations within ninety days of enacting the legislation,
but the DEA responded that this requirement would be burdensome
and should be lengthened.56 In response to the DEA, Congress ex-
tended the requirement to allow the DEA to promulgate final regula-
tions within one year of enactment.57 This change in the time
requirement to promulgate this new rule can benefit both the DEA
and practitioners hoping to receive the special registration.58 With the
original ninety-day requirement, the DEA would have published a
rule without giving the public time for notice and comment.59 This
would have given the DEA the ability to put into force a rule that
ultimately may not help the current issue in telemedicine prescrib-
ing.60 But, by changing the time requirement to one year, the DEA
can propose the rule and give the healthcare providers, prescribers,
and patients who care most about this issue ample time to comment.61
This gives the DEA the proper duration and ability to consider the
public’s view on the rule and tailor the rule accordingly.62
Although this legislation has the potential to bring about positive
change in the telemedicine industry by getting medical treatment to
those who may not be reached otherwise, there are still many uncer-
tainties in how this legislation will play out and ultimately affect the
telemedicine landscape.
B. Problems with the Legislation
While great progress may come from the Special Registration for
Telemedicine Clarification Act of 2018, some loopholes remain by
54. Id.
55. Id.
56. Bradley S. Davidsen & Daniel Kim, Law Urging DEA to Promulgate Rules for
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which the DEA could effectively inhibit the number of providers re-
ceiving special registration.
First, a potential issue is the scope of the promulgated regulation,
which could be written either very broadly or very narrowly. Con-
gressman Greg Walden described a possible narrow rule as one that
would grant the special registration “for emergency situations, like the
lack of access to an in-person specialist.”63 Additionally, Congressman
Buddy Carter stated that the original purpose of the special registra-
tion was for “legitimate emergency situations.”64 This interpretation
differs from the language of the Ryan Haight Act. The special regis-
tration exception’s original language states the exception may be
given to a practitioner who “demonstrates a legitimate need for the
special registration.”65 A plain reading of this language seems broader
than the description Congressmen Walden and Carter read into the
exception. This alone could be an issue because many legitimate prac-
titioners believe that as a result of this new legislation, they will have
the opportunity to receive the special registration. But, in reality, the
newly promulgated rule could be written so narrowly that it would be
nearly impossible to receive the special registration from the DEA.
The ATA has written the DEA a letter offering recommendations
on the special registration process presented in this legislation. This
letter offers five recommendations for the DEA, stating that the DEA
should (1) update the current DEA registrations process to specify
between traditional and telehealth prescribing privileges, (2) allow
sites and prescribers to register for telehealth, (3) allow for a comment
period for the public within the one-year timeline allowed before the
special registration activation, (4) ensure that the special registration
is not restricted to just one discipline, and (5) allow telehealth provid-
ers to apply for the registration in multiple states at once.66 The ATA
stated that “[t]he telehealth community has long advocated for activa-
tion of special registration to relieve the regulatory impasse that con-
fronts many telehealth prescribers.”67  The DEA should follow these
recommendations offered by the ATA because the ATA can foresee
the positive impact that the special registration could have on
telemedicine. The ATA has explained that the special registration
would “combat the opioid crisis, but also provide the broad range of
medical disciplines an avenue to expand access to quality care.”68
63. Davidsen & Kim, supra note 56.
64. Id.
65. 21 U.S.C. § 831 (2012).
66. ATA Sends Recommendation Regarding the Special Registration Process for
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Second, as previously discussed, many states like Alaska and Texas
are revising legislation that allows a practitioner to perform
telemedicine services without a prior in-person exam. While these
states are maintaining pace with technology, the federal law makes
some of this legislation obsolete because federal law preempts state
law. Therefore, while this update to the special registration law would
be progress toward resolving the issue of getting medication to those
in need who do not have the means to meet with a practitioner in
person, the overall issue requires a more comprehensive solution.
Since the passage of the Ryan Haight Act in 2008, there have been
technological advancements that can not only help the DEA track
controlled substance prescribing, but can also assist legitimate
telehealth practitioners to create the practitioner–patient relationship
by using a modern audiovisual medium. Such technological advance-
ments must be taken into account by the federal government, and
changes should be made by the federal government to help legitimate
telehealth practitioners get medication to those in need.
This issue is analogous to changes in the marijuana laws that are
being seen around the country. States are legalizing the sale and pos-
session of marijuana,69 much like they are legalizing the use of
telemedicine services without requiring an in-person exam. But while
states are legalizing the ability to prescribe controlled substances with-
out an in-person exam, it is still a federal crime to do so—much like
the sale or possession of marijuana has been legalized by some state
laws but remains illegal at the federal level.70 Therefore, until the fed-
eral laws governing telemedicine services become less restrictive,
there will remain a federal penalty that may be enforced by the fed-
eral government. But if the federal statutes follow what a number of
states have done, there will likely be a boom in both the marijuana
and telemedicine industries.
Therefore, while the Special Registration for Telemedicine Clarifi-
cation Act of 2018 has the structure to potentially be very beneficial to
legitimate telemedicine providers who want to help unreached com-
munities through telemedicine services, the DEA could still promul-
gate a regulation that makes receiving the special registration almost
impossible. This type of regulation would not have much of a positive
effect on the telemedicine industry or those who could benefit from
telemedicine services.
69. See Recreational Weed States – States That Have Legalized Weed, WORLD POP-
ULATION REV. (Oct. 7, 2019), http://worldpopulationreview.com/states/recreational-
weed-states/ [https://perma.cc/BJQ2-Z73A].
70. 21 U.S.C. § 812(c) (2012); Id. §§ 841–844 (2012).
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IV. MEDICARE REIMBURSEMENT
While the DEA continues to drag its feet, other agencies are mak-
ing significant progress toward expanding telehealth. By publishing
several new rules, the Centers for Medicare and Medicaid Services
(“CMS”) has made it possible for Medicare users to have access to
healthcare services provided remotely by telehealth methods.71
A. Change in Law for Reimbursement of Telehealth Services
CMS officials stated that the rule, effective as of January 1, 2019,
was promulgated to support access to health care using telecommuni-
cations technology.72 Medicare will now reimburse providers for new
uses of technology-based services.73 This demonstrates that CMS be-
lieves telehealth services can provide increased access to low-cost and
high-quality health services and that CMS will allow for more flexibil-
ity to use these services by reimbursing a broader range of services.74
CMS administrator Seema Verma supports the rules expanding Medi-
care and said that “[t]his provides opportunities for patients around
communicating with providers remotely . . . [t]his is an historic change
in terms of increasing access and it’s also a great example of some of
the efforts that we’re trying to make around supporting innovation.”75
Verma spoke about how access to care is an issue around the country,
in both rural and urban areas, and that CMS hopes to use technology
to provide better access.76
1. Remote Evaluations and Virtual Check-Ins
Two key updates in CMS’s rules are (1) the reimbursement for the
evaluation of pre-recorded patient information, and (2) brief commu-
nication technology-based services (virtual check-in).77 The new rules
permit the use of store-and-forward asynchronous telemedicine tech-
nologies that include pre-recorded still or video images submitted only
71. HOGAN LOVELLS, MEDICARE EXPANDS PAYMENT FOR AND COVERAGE OF
TELEHEALTH AND SIMILAR SERVICES 1 (2018), https://www.hoganlovells.com/~/me-
dia/hogan-lovells/pdf/2018/2018_11_07_health_alert_medicare_further_expands_pay-
ment_for_and_coverage_of_telehealth_and_similar_services.pdf [https://perma.cc/
36BE-YXHB] [hereinafter Medicare Further Expands Payment for and Coverage of
Telehealth and Similar Services].
72. Heather Landi, BREAKING: CMS Publishes CY 2019 Physician Fee Sched-




74. Medicare Further Expands Payment for and Coverage of Telehealth and Simi-
lar Services, supra note 71.
75. Landi, supra note 72.
76. Id.
77. Medicare Further Expands Payment for and Coverage of Telehealth and Simi-
lar Services, supra note 71, at 2.
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by the patient.78 The patient cannot give information solely through
filling out a questionnaire.79 After the information is given and the
practitioner reviews the image or video, the practitioner must respond
within twenty-four hours. The response does not have to be over an
asynchronous forum and may be delivered by phone call, e-mail, or
another form of communication.80 CMS has put limits on this reim-
bursement by stating the reimbursement is only available to estab-
lished patients.81 An established patient is one “who has received
professional services from the physician or qualified healthcare pro-
fessional or another physician or qualified healthcare professional of
the exact same specialty and subspecialty who belongs to the same
group practice, within the past [three] years.”82 While there are gaps
in this new rule from CMS, reimbursing for asynchronous image re-
view is a promising step toward bringing Medicare reimbursement to
virtual care services.83
2. Telehealth to Treat Substance Abuse Disorders
A provision passed as a part of the SUPPORT for Patients and
Communities Act expands the ability of practitioners to be reim-
bursed for telehealth treatment of substance abuse disorders.84 The
change eliminates many of the geographic restrictions that are applied
to most telehealth services for treatment of individuals diagnosed with
substance abuse or mental health disorders.85 The patient’s home has
been included as an originating site, allowing for telehealth treatment
to be performed with the patient remaining in his or her house, but
without the added charge of a facility fee.86
B. What is a “Telehealth Service”
What is recognized as a “telehealth service” under Medicare is very
important in determining whether a practitioner will be reimbursed.
Under Medicare, “telehealth services” are those in which practitioners
typically conduct in-person examinations, but “are instead furnished
using interactive, real-time telecommunication technology.”87 While
the CMS rule changes have presented positive moves toward ex-
78. Nathaniel M. Lacktman, Understanding Medicare’s New Remote Evaluation of
Pre-Recorded Patient Information (Asynchronous Telemedicine), FOLEY & LARDNER
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panding telehealth services, CMS continues to require an in-person
exam before reimbursing for telehealth services, except if certain re-
quirements are met.88 CMS has stated that “it is critical that the initial
hospital visit by the admitting practitioner be conducted in person to
ensure that the practitioner . . . comprehensively assesses the patient’s
condition upon admission to the hospital . . . .”89
However, there are conditions that must be met for a practitioner to
use telehealth services as a substitute for an in-person exam.90 Those
conditions require that:
(1) [t]he beneficiary is located in a qualifying rural area; (2) [t]he
beneficiary is located at one of eight qualifying originating sites; (3)
[t]he services are provided by one of ten distant site practitioners
eligible to furnish and receive Medicare payment for telehealth ser-
vices; (4) [t]he beneficiary and distant site practitioner communicate
via an interactive audio and video telecommunications system that
permits real-time communication between them; and (5) [t]he Cur-
rent Procedural Terminology/Healthcare Common Procedure Cod-
ing System (CPT/HCPCs) code for the service itself is named on the
list of covered Medicare telehealth services.91
These requirements are specific, but it is evident that CMS is willing
to allow an exception to the in-person requirement when the circum-
stances warrant it. For example, as stated above, CMS is now allowing
patients who have been diagnosed with substance abuse or mental
health disorders to use their home originating site to qualify to receive
telehealth services, as well as removing the geographic requirements
to qualify for telehealth services.92 This allows a practitioner to get
needed care to those with certain mental disorders without having to
perform an in-person exam and without requiring the patient to be in
the presence of another practitioner.93
The rule changes CMS promulgated recognize the comfort patients
and healthcare providers have with using communication technology
and the value it brings to the healthcare industry.94 CMS has realized
the increased demand for convenient telehealth services, and CMS
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V. NEEDED REFORM OF TELEMEDICINE
A. Who Can Benefit from Changes
The expansion of telemedicine services can benefit a very wide
range of individuals, but the main focus of much of current legislation
and those who practice medicine can be grouped into three popula-
tions: (1) those with substance abuse disorders, (2) those with legiti-
mate mental health issues, and (3) individuals who live in rural areas
and do not have the means to travel long distances to reach a health-
care professional.
1. Individuals with Substance Abuse Disorders
An expansion of telehealth services is needed and can bring serious
improvements to the opioid crisis by bringing medical services directly
to the homes of those with substance abuse issues. Senator Brian
Schatz from Hawaii has been a longtime advocate for telehealth ser-
vices.96 He stated that “[o]pioid addiction is a national epidemic, and
we need a comprehensive approach to address it.”97 In the United
States, over 100 Americans die as a result of a drug overdose every
day.98 Although the deaths involving prescription painkillers have be-
gun to level off, the data on fatalities involving heroin and illicitly-
manufactured fentanyl has been astounding, showing that the number
of deaths quintupled between 2010 and 2016.99 The opioid crisis led to
the passage of the SUPPORT for Patients and Communities Act,
which seeks a way to get individuals with substance abuse disorders
the help they need.100
Treatment for substance use disorders usually involves an approach
that includes behavioral counseling and medication-assisted treatment
(“MAT”).101 For opioid addiction, MAT uses medications such as
methadone, naltrexone, and buprenorphine, which work by blocking
the effects of narcotics and/or by reducing withdrawal risk or symp-
toms.102 Using these MAT medications is controversial because peo-
ple who are not addicted to opioids can experience euphoria when
using these drugs.103 But the National Institutes of Health stated that
individuals who have developed a high tolerance for opioids do not
96. Eric Wicklund, Congress Takes Aim at Opioid Crisis with Telehealth Expan-
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experience this euphoria and that these MAT drugs are essential for
patients to function well enough to participate in other treatments.104
The Ryan Haight Act was put into place to stop the illegal prescrib-
ing of controlled substances that were not medically necessary, but it
has effectively blocked a channel for those struggling with substance
abuse disorders to get treatments.105 MAT drugs are controlled sub-
stances and as such are restricted by the Ryan Haight Act.106 There-
fore, individuals with substance abuse disorders who are not able to
see a physician to start MAT will not receive the treatment necessary
to cure their illnesses.107 The Ryan Haight Act effectively eliminated
substance abuse treatment via telemedicine.108 And because of a lack
of qualified physicians in opioid-use treatment, many individuals with
substance abuse disorders go untreated.109 Barriers to accessing health
care result in untreated patients and overworked providers, illuminat-
ing the fact that telemedicine reform is needed.110
2. Those with Legitimate Mental Health Issues
Individuals with legitimate mental health issues can greatly benefit
from having access to medication that can help them treat their condi-
tions. The Unites States is currently facing a mental health crisis, with
one in five adults experiencing some type of mental health issue.111
Over 43 million Americans experienced a mental health issue in 2017,
and of these 43 million, 4% suffer from a mental health issue so severe
it has a serious impact on their daily life activities.112 These mental
health issues include post-traumatic stress disorder, anxiety disorders,
major depression, bipolar disorder, and schizophrenia.113 The United
States loses almost $1 trillion per year in mental health care costs and
lost wages resulting from mental health issues.114 The expansion of
telemedicine to treat mental health issues in the United States will not
only help individual citizens, but the economy as well.
3. Individuals Living in Rural and Low-Income Areas
A major issue for those with mental health and/or substance abuse
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vulnerable populations in the United States that has little access to
mental health care or substance abuse treatment include those living
in rural or urban low-income areas.115 The issue for these groups is the
long geographic distances one must travel to meet with a healthcare
professional that is qualified to treat them.116 Mental health profes-
sional scarcity is a contributing factor to the long distances a patient
must travel to meet with a healthcare provider. In the United States,
nearly 60% of people living in rural areas live in one of the over 3,900
mental health professional shortage areas.117 Telemedicine has the
ability to reduce the number of Americans living with mental health
and substance abuse issues by getting medication to individuals living
in rural and low-income areas that would otherwise not have access to
care.
4. The Elderly
Additionally, the elderly population as a whole—especially those
living in rural areas—could benefit from an expansion of telemedicine
services.118 It is estimated that one in four elderly individuals has some
form of mental illness.119 Much of the elderly population lacks ade-
quate transportation to access competent health care.120 These issues
must be addressed in some way. Telemedicine gives those that live in
rural areas or have limited mobility a drastic improvement in their
ability to access healthcare services, thereby closing the gap between
those in need and practitioners that can provide help.121 The ex-
panded use of telemedicine could be a tool used in providing what the
Centers for Disease Control and Prevention (“CDC”) have deter-
mined are the ten “essential public health services.”122 There have
been concerns with insurance coverage, but as stated above, CMS has
made changes that show it is beginning to see the benefits of using
technological advancements to reach individuals who have barriers to
health care, especially individuals fighting mental illness.123 Now it is
the federal government’s turn to rise to the occasion and do the same.
There is a vast range of unreached individuals who are barred from
receiving proper health care. Expanding access to medication to those
with substance abuse disorders, mental health diseases, and individu-
als living in rural areas would be a great step toward reaching these
115. Id. at 38–39.
116. Id. at 39.
117. Id. at 38.
118. Id. at 34.
119. Id.
120. Id.
121. Bryant, supra note 2, at 1.
122. Id.
123. Medicare Further Expands Payment for and Coverage of Telehealth and Simi-
lar Services, supra note 71.
492 TEXAS A&M LAW REVIEW [Vol. 7
classifications of individuals with poor health care. Telemedicine is a
powerful means by which access to care can be greatly improved.
B. What Changes Should be Made
Changes to the federal Ryan Haight Act should be made to mitigate
mental health and substance abuse issues, while also helping individu-
als in rural locations access quality health care. Without being overly
permissive, there are a number of ways in which Congress can pass
legislation that will help alleviate the issue of lack of health care while
still regulating controlled substance prescribing. Changes in
telemedicine laws would help the law catch up with innovation be-
cause we now have modern technology that allows a physician to eval-
uate a patient over an audiovisual communication. Such technology
was not available when the Ryan Haight Act was passed in 2008.
The American Medical Association (“AMA”) has noted in its Eth-
ics Opinion 1.2.12 that “innovation in technology, including informa-
tion technology, is redefining how people perceive time and
distance.”124 The Opinion goes on to say that innovation is “reshaping
how individuals interact with and relate to others, including when,
where, and how patients and physicians engage with one another.”125
This Ethics Opinion is titled “Ethical Practice in Telemedicine,” and
observes that telehealth has the ability to offer multiple methods of
delivering care, but that patients “need to be able to trust that physi-
cians will place patient welfare above other interests.”126 The AMA
expects physicians to uphold the normal standards of professionalism
required in an in-person exam by following ethical guidelines and the
applicable law.127
While the AMA Ethics Opinion supports following the law, which
requires an in-person examination before prescribing controlled sub-
stances, the ethical standards set out in the Ethics Opinion could be
complied with if the law was changed to allow controlled substance
prescribing through telemedicine.128 For example, the AMA believes
that healthcare institutions and professional organizations should
monitor the telehealth landscape by supporting refinement and devel-
opment of telehealth technologies to ensure that the services are safe
for patients and that physicians are delivering quality care.129 Such
institutions should advocate for policies and initiatives that promote
access to telehealth services for those who can benefit.130
124. Code of Medical Ethics Opinion 1.2.12, AM. MED. ASS’N, https://www.ama-
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Additionally, the AMA encourages physicians to identify negative
consequences as technologies evolve while still spreading the news of
both positive and negative outcomes of telehealth.131 This desire to
promote accessibility for those who could benefit from telehealth can
be achieved by amending the Ryan Haight Act. The correct regula-
tions for prescribing controlled substances would support the develop-
ment of telehealth technologies while ensuring a safe service for
patients through a proper monitoring system and an audiovisual
medium.
1. Federal Changes and Regulation
Like CMS, Congress needs to take steps to recognize innovations in
communication technologies. There are ways in which treatment
through audiovisual communication technology can be effectively sub-
stituted for an in-person exam. Like CMS creating exceptions for
those with substance abuse issues, Congress should make similar ex-
ceptions for qualifying classes of individuals. Francesca Ozinal, of the
law firm Epstein Becker & Green, stated that she believes Congress
should amend the Ryan Haight Act to focus more on the proper stan-
dard of care for the patient rather than requiring an in-person
exam.132 Physicians have a legal and ethical obligation to follow the
proper standard of care for each patient.133 There are many situations
in which the standard of care can be met by using an audiovisual me-
dium rather than requiring an in-person exam.
However, controlled substance prescribing should not be a free-for-
all that allows any online pharmacy to prescribe medication to any
person who merely fills out a questionnaire. There should be laws en-
acted that allow the DEA to regulate controlled substance prescribing
so legitimate telemedicine providers can provide beneficial treatment
to those in need. A step in the right direction for federal law would be
to emphasize the use of telemedicine in rural and low-income urban
areas because they are most impacted by the current restrictions. Ad-
ding a geographic layer to the law would put a sensible restriction on
prescribing controlled substances, rather than completely banning
prescribing a controlled substance without an in-person exam. As
shown above, many Americans have barriers that prevent them from
getting to a qualified practitioner who can give them the treatment
and prescriptions they need. Allowing individuals living in remote ge-
ographic areas to consult a practitioner through audiovisual technol-
ogy and obtain a prescription could be a huge step toward fixing the
provider shortage. Such change would also create progress toward
131. Id.
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limiting the number of individuals suffering from mental illness or
substance abuse issues in the United States today.
There are many ways in which the DEA can regulate controlled
substance prescribing without the burden currently placed on
telemedicine providers. First, there should be a required meeting be-
tween the patient and a qualified practitioner through an audiovisual
communication technology, to substitute for an in-person exam, so
that the patient and practitioner actually have a one-on-one encoun-
ter. This should be an absolute requirement, and no controlled sub-
stance should be prescribed before this evaluation occurs. This type of
required interaction would likely have prevented the issue in the case
of Ryan Haight. Because Ryan Haight was only required to complete
an online questionnaire before receiving prescription drugs, there was
no face-to-face meeting with a physician in any form, either in-person
or through an audiovisual communication technology.134
Second, to properly regulate controlled substance prescribing, the
DEA must require an extensive documenting process. This would
help the DEA track what controlled substances are being prescribed,
as well as when and where they are being prescribed. A database for
telemedicine providers to report their prescribing quantities and proof
of evaluation would be an efficient way to keep track of prescribing
and would force practitioners to operate legally and legitimately.
Additionally, the DEA should keep an eye out for geographic areas
in which more than the projected amount of controlled substances is
being prescribed. Such monitoring would be essential, because al-
though a requirement of a face-to-face meeting through an audiovi-
sual communication technology would help to legitimize telemedicine
prescribing, there will likely continue to be corrupt physicians who
attempt to take advantage of the system. Therefore, if the DEA were
to see a spike in controlled substance prescribing by a certain practi-
tioner or in a geographical area, it could perform an investigation to
ensure there is no illegal activity. This step would help monitor con-
trolled substance prescribing as a whole because physicians who have
performed an in-person exam may overprescribe as well.
If these steps were taken, the probability of another tragedy like the
one in the case of Ryan Haight would be nearly completely elimi-
nated, and health care would reach those in desperate need of it. Ad-
ditionally, these suggestions would help the DEA monitor what
controlled substances are being prescribed while still letting legitimate
telemedicine providers make a living by helping those in need, so long
as they follow the proper steps and standard of care.
134. Lipman, supra note 5, at 545.
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2. Deference to State Laws
Additionally, federal law should defer to the states, allowing them
to decide how strict their telemedicine laws should be. The federal law
should be a way to regulate controlled substances as a whole, but state
legislatures should decide if their particular state has need for a physi-
cian to prescribe controlled substances through telemedicine without
an in-person examination. This deference would be a practical way of
continuing to solve the issue at hand. Smaller, more populous states—
that do not have as big of a challenge in getting their residents health
care—may still decide that they do want practitioners to conduct an
in-person exam before prescribing any drug through telemedicine. But
larger, less populous states may decide that many of their residents
have barriers to proper health care, whether they be geographic or
financial. As such, they may want to allow controlled substance pre-
scribing through telemedicine, so long as statutory requirements are
met for establishing a practitioner–patient relationship. The latter mir-
rors Texas’ approach135 as a state where there are both rural commu-
nities and individuals suffering with substance abuse and mental
health issues who need additional help to access health care. Texas, as
well as many other states, has put laws into effect that allow for the
practitioner–patient relationship to be formed by way of an audiovi-
sual technology. Now, the federal government should step in and do
its part by amending the Ryan Haight Act.
VI. CONCLUSION
The Ryan Haight Act should be amended because it overly restricts
legitimate telemedicine providers, and since its enactment, technology
has been developed that can help regulate telemedicine prescribing
more effectively. Future regulation should be done in a way that still
strictly monitors the telemedicine industry, but also provides medical
treatment to individuals who can more easily be reached through
telemedicine. Additionally, the Ryan Haight Act has prevented indi-
viduals from getting treatment they need—a consequence unintended
by Congress when it passed the Act.
The Special Registration for Telemedicine Clarification Act of 2018
has the potential to be a great step toward improving telemedicine
laws, but the uncertainty of the law could lead to little real benefit to
the telemedicine industry and the patients who lack access to care.
Congress should amend the Ryan Haight Act to mirror the laws
that many states have been adopting, specifically so telemedicine
providers can use audiovisual mediums to provide legitimate health
care to individuals in need without the requirement of a prior in-per-
son exam. This type of legislation would not only help to eliminate the
135. See TEX. OCC. CODE § 111.005.
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opioid crisis, but would give healthcare access to those who have geo-
graphic barriers and individuals who struggle with mental health is-
sues. With the correct type of regulation, online prescribers and
pharmacies can have a positive effect on healthcare, not the negative
effect seen in the tragic story of Ryan Haight.
